Vanessa Wu

759 total citations
13 papers, 414 citations indexed

About

Vanessa Wu is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Vanessa Wu has authored 13 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Hepatology and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Vanessa Wu's work include Liver Disease Diagnosis and Treatment (9 papers), Hepatitis C virus research (9 papers) and Hepatitis B Virus Studies (8 papers). Vanessa Wu is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Hepatitis C virus research (9 papers) and Hepatitis B Virus Studies (8 papers). Vanessa Wu collaborates with scholars based in China, United States and Macao. Vanessa Wu's co-authors include George Lau, Dong Ji, Yudong Wang, Jing Chen, Cheng Wang, Guofeng Chen, Johan Karlberg, Qing Shao, Nancy Y. Lee and C. Jillian Tsai and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

Vanessa Wu

12 papers receiving 400 citations

Peers

Vanessa Wu

EPIDE

HEPAT

OTORH

PRM

Baris Deniz United States

Klára Werling Hungary

Chun‐Ming Hong Taiwan

Lina Ma China

Andreea M. Catana United States

Mohammed Shatat Egypt

A. Abdo Saudi Arabia

Jean‐Pierre Giordanella France

Erica Nicola Lynch Italy

Yanjie Ren Qatar

Baris Deniz United States

Vanessa Wu

245 ×0.8

EPIDE

249 ×0.9

HEPAT

8 ×0.1

9 ×0.2

OTORH

23 ×0.6

PRM

Citations per year, relative to Vanessa Wu Vanessa Wu (= 1×) peers Baris Deniz

Countries citing papers authored by Vanessa Wu

Since Specialization

Citations

This map shows the geographic impact of Vanessa Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Wu more than expected).

Fields of papers citing papers by Vanessa Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanessa Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Wu. The network helps show where Vanessa Wu may publish in the future.

Co-authorship network of co-authors of Vanessa Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Vanessa Wu. A scholar is included among the top collaborators of Vanessa Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanessa Wu. Vanessa Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Lee, Nancy Y., Nadeem Riaz, Vanessa Wu, et al.. (2022). A Pilot Study of Durvalumab (MEDI4736) with Tremelimumab in Combination with Image-Guided Stereotactic Body Radiotherapy in the Treatment of Metastatic Anaplastic Thyroid Cancer. Thyroid. 32(7). 799–806. 20 indexed citations

Ji, Dong, Guofeng Chen, Xiao-Xia Niu, et al.. (2021). Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up study. SHILAP Revista de lepidopterología. 10. 100090–100090. 23 indexed citations

Dalenberg, Constance J., et al.. (2019). Consequences of abuse by religious authorities: A review.. Traumatology An International Journal. 25(4). 242–255. 15 indexed citations

Ji, Dong, Guofeng Chen, Cheng Wang, et al.. (2019). Increase in Incidence of Hepatocellular Carcinoma in Chronic Hepatitis C Chinese After Sustained Virologic Response with Direct Acting Antiviral Agents as Compared to Pegylated Interferon Plus Ribavirin Therapy: A Prospective Open-Label Study. SSRN Electronic Journal.

Sherman, Eric J., C. Jillian Tsai, Wanqing Iris Zhi, et al.. (2019). Pilot study combining PD-L1 antibody durvalumab (D) with CTLA-4 antibody tremelimumab (T) and stereotactic body radiotherapy (SBRT) to treat metastatic anaplastic thyroid cancer (ATC).. Journal of Clinical Oncology. 37(15_suppl). 6088–6088. 7 indexed citations

Damerla, Rama Rao, Nancy Y. Lee, Rachna Shah, et al.. (2019). Detection of Early Human Papillomavirus–Associated Cancers by Liquid Biopsy. JCO Precision Oncology. 3(3). 1–17. 92 indexed citations

Ji, Dong, Yiming Fu, Qing Shao, et al.. (2018). The 10-year chronic liver disease spectrum evolution in China: experience from the largest tartiary special hospital with 21382 liver biopsy cases. Journal of Hepatology. 68. S155–S156. 2 indexed citations

Ji, Dong, et al.. (2017). No increase in the occurrence rate of hepatocellular carcinoma in Chinese treated by direct-acting antivirals compared to Interferon after eradication of hepatitis c virus: a long-term follow-up. Journal of Hepatology. 66(1). S23–S23. 4 indexed citations

Ji, Dong, et al.. (2017). Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: a systematic review and meta-analysis. Journal of Hepatology. 66(1). S296–S297. 6 indexed citations

10.

Chen, Guofeng, Cheng Wang, Jing Chen, et al.. (2017). Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: A systematic review and meta‐analysis. Hepatology. 66(1). 13–26. 105 indexed citations

11.

Fan, Jian‐Gao, Dong Ji, Qing Shao, et al.. (2017). Long-term disease progression in chronic hepatitis B Chinese patients with comorbid nonalcoholic fatty liver disease. Journal of Hepatology. 66(1). S416–S417. 1 indexed citations

12.

Wang, Cheng, Dong Ji, Jing Chen, et al.. (2016). Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral Agents. Clinical Gastroenterology and Hepatology. 15(1). 132–136. 125 indexed citations

13.

Ji, Dong, Guofeng Chen, Cheng Wang, et al.. (2016). Twelve-week ribavirin-free direct-acting antivirals for treatment-experienced Chinese with HCV genotype 1b infection including cirrhotic patients. Hepatology International. 10(5). 789–798. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact